rs2069709

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP5BP4BS1_SupportingBS2

The ENST00000536914.1(IFNG-AS1):​n.337-74606C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00692 in 152,262 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).

Frequency

Genomes: 𝑓 0.0069 ( 11 hom., cov: 31)

Consequence

IFNG-AS1
ENST00000536914.1 intron

Scores

2

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 0.404

Publications

37 publications found
Variant links:
Genes affected
IFNG-AS1 (HGNC:43910): (IFNG antisense RNA 1)
IFNG (HGNC:5438): (interferon gamma) This gene encodes a soluble cytokine that is a member of the type II interferon class. The encoded protein is secreted by cells of both the innate and adaptive immune systems. The active protein is a homodimer that binds to the interferon gamma receptor which triggers a cellular response to viral and microbial infections. Mutations in this gene are associated with an increased susceptibility to viral, bacterial and parasitic infections and to several autoimmune diseases. [provided by RefSeq, Dec 2015]
IFNG Gene-Disease associations (from GenCC):
  • immunodeficiency 69
    Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PP5
Variant 12-68159923-C-A is Pathogenic according to our data. Variant chr12-68159923-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 14724.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00692 (1053/152262) while in subpopulation AFR AF = 0.0241 (1000/41534). AF 95% confidence interval is 0.0228. There are 11 homozygotes in GnomAd4. There are 495 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 11 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000536914.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFNG
NM_000619.3
MANE Select
c.-308G>T
upstream_gene
N/ANP_000610.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFNG-AS1
ENST00000536914.1
TSL:5
n.337-74606C>A
intron
N/A
IFNG
ENST00000229135.4
TSL:1 MANE Select
c.-308G>T
upstream_gene
N/AENSP00000229135.3

Frequencies

GnomAD3 genomes
AF:
0.00691
AC:
1051
AN:
152144
Hom.:
12
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00384
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00692
AC:
1053
AN:
152262
Hom.:
11
Cov.:
31
AF XY:
0.00665
AC XY:
495
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0241
AC:
1000
AN:
41534
American (AMR)
AF:
0.00235
AC:
36
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68018
Other (OTH)
AF:
0.00380
AC:
8
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
52
103
155
206
258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00980
Hom.:
4
Bravo
AF:
0.00790
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Pathogenic
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Acquired immunodeficiency syndrome, rapid progression to (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
16
DANN
Benign
0.79
PhyloP100
0.40
PromoterAI
-0.0022
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2069709; hg19: chr12-68553703; API